Back to Search
TILDEN HUGHES, M.D.
M.D.
Family Medicine Physician
NPI: 1457554073IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
A95323(CA)
Education
GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE
Class of 2004
Research & Publications (20)
Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase.
PMID 19652056·J Clin Oncol·2009
3-trial
Clinical strategies to achieve an early and successful response to tyrosine kinase inhibitor therapy.
PMID 19621544·Semin Hematol·2009
8-other
Identification of the high affinity binding site in the Streptococcus intermedius toxin intermedilysin for its membrane receptor, the human complement regulator CD59.
PMID 19200600·Mol Immunol·2009
7-preclinical
Emerging therapies for metabolic diseases--the focus is on diabetes and obesity.
PMID 19482541·Curr Opin Chem Biol·2009
6-review
Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22.
PMID 19244159·Blood·2009
8-other
7-[1H-Indol-2-yl]-2,3-dihydro-isoindol-1-ones as dual Aurora-A/VEGF-R2 kinase inhibitors: design, synthesis, and biological activity.
PMID 18718756·Bioorg Med Chem Lett·2008
7-preclinical
Sexual orientation and smoking: results from a multisite women's health study.
PMID 18649240·Subst Use Misuse·2008
4-observational
A novel 5-[1,3,4-oxadiazol-2-yl]-N-aryl-4,6-pyrimidine diamine having dual EGFR/HER2 kinase activity: design, synthesis, and biological activity.
PMID 18678484·Bioorg Med Chem Lett·2008
4-observational
Is drug treatment superior to allografting as first-line therapy in chronic myeloid leukemia?
PMID 17940526·Nat Clin Pract Oncol·2008
8-other
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy.
PMID 18768781·Blood·2008
3-trial
Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.
PMID 17643375·Mol Cell·2007
8-other
Using the IAO Tier Advancement CD "Successfully achieving your IAO diplomate status".
PMID 18220010·Int J Orthod Milwaukee·2007
8-other
4-Aryl-5-cyano-2-aminopyrimidines as VEGF-R2 inhibitors: synthesis and biological evaluation.
PMID 17481894·Bioorg Med Chem Lett·2007
7-preclinical
Childhood risk factors for alcohol abuse and psychological distress among adult lesbians.
PMID 17628667·Child Abuse Negl·2007
8-other
H2B ubiquitylation acts as a barrier to Ctk1 nucleosomal recruitment prior to removal by Ubp8 within a SAGA-related complex.
PMID 17643376·Mol Cell·2007
8-other
Prediction and testing of novel transcriptional networks regulating embryonic stem cell self-renewal and commitment.
PMID 18371337·Cell Stem Cell·2007
8-other
Molecular monitoring of BCR-ABL as a guide to clinical management in chronic myeloid leukaemia.
PMID 16426942·Blood Rev·2006
6-review
Regulation of axin2 expression at the levels of transcription, translation and protein stability in lung and colon cancer.
PMID 15885887·Cancer Lett·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2030 SUTTER PLACE, #2000
DAVIS, CA 95616 - Phone
- (530) 750-5800
Quick Facts
- NPI
- 1457554073
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 22
- Publications
- 20
Are you this provider?
Claim Your Profile